关注
Scott J. Diede, MD, PhD
Scott J. Diede, MD, PhD
在 merck.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy
A Ribas, R Dummer, I Puzanov, A VanderWalde, RHI Andtbacka, ...
Cell 170 (6), 1109-1119. e10, 2017
11092017
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double …
GV Long, R Dummer, O Hamid, TF Gajewski, C Caglevic, S Dalle, ...
The Lancet Oncology 20 (8), 1083-1097, 2019
5672019
Telomerase-mediated telomere addition in vivo requires DNA primase and DNA polymerases α and δ
SJ Diede, DE Gottschling
Cell 99 (7), 723-733, 1999
4801999
Durable complete response after discontinuation of pembrolizumab in patients with metastatic melanoma
C Robert, A Ribas, O Hamid, A Daud, JD Wolchok, AM Joshua, WJ Hwu, ...
Journal of clinical oncology 36 (17), 1668-1674, 2018
3882018
The function of a stem-loop in telomerase RNA is linked to the DNA repair protein Ku
SE Peterson, AE Stellwagen, SJ Diede, MS Singer, ZW Haimberger, ...
Nature genetics 27 (1), 64-67, 2001
2982001
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of …
B Geoerger, HJ Kang, M Yalon-Oren, LV Marshall, C Vezina, A Pappo, ...
The Lancet Oncology 21 (1), 121-133, 2020
1892020
Exonuclease activity is required for sequence addition and Cdc13p loading at a de novo telomere
SJ Diede, DE Gottschling
Current Biology 11 (17), 1336-1340, 2001
1702001
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial
JJ Luke, P Rutkowski, P Queirolo, M Del Vecchio, J Mackiewicz, ...
The Lancet 399 (10336), 1718-1729, 2022
1532022
Three-year overall survival for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.
C Robert, A Ribas, O Hamid, A Daud, JD Wolchok, AM Joshua, WJ Hwu, ...
Journal of Clinical Oncology 34 (15_suppl), 9503-9503, 2016
1432016
Epacadostat plus pembrolizumab versus pembrolizumab alone in patients with unresectable or metastatic melanoma: Results of the phase 3 ECHO-301/KEYNOTE-252 study
GV Long, R Dummer, O Hamid, T Gajewski, C Caglevic, S Dalle
J Clin Oncol 36 (15_suppl), 108, 2018
1402018
Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy
A Ribas, R Dummer, I Puzanov, A VanderWalde, RHI Andtbacka, ...
Cell 174 (4), 1031-1032, 2018
1252018
MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state
Z Yang, KL MacQuarrie, E Analau, AE Tyler, FJ Dilworth, Y Cao, SJ Diede, ...
Genes & development 23 (6), 694-707, 2009
1042009
KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma
PF Ferrucci, AM Di Giacomo, M Del Vecchio, V Atkinson, H Schmidt, ...
Journal for immunotherapy of cancer 8 (2), 2020
1012020
A phase Ib study of pembrolizumab as second-line therapy for Chinese patients with advanced or metastatic melanoma (KEYNOTE-151)
L Si, X Zhang, Y Shu, H Pan, D Wu, J Liu, F Lou, L Mao, X Wang, X Wen, ...
Translational oncology 12 (6), 828-835, 2019
942019
DNA methylation of developmental genes in pediatric medulloblastomas identified by denaturation analysis of methylation differences
SJ Diede, J Guenthoer, LN Geng, SE Mahoney, M Marotta, JM Olson, ...
Proceedings of the National Academy of Sciences 107 (1), 234-239, 2010
792010
Comparison of genome-wide binding of MyoD in normal human myogenic cells and rhabdomyosarcomas identifies regional and local suppression of promyogenic transcription factors
KL MacQuarrie, Z Yao, AP Fong, SJ Diede, ER Rudzinski, DS Hawkins, ...
Molecular and cellular biology 33 (4), 773-784, 2013
762013
Genome-wide DNA methylation studies suggest distinct DNA methylation patterns in pediatric embryonal and alveolar rhabdomyosarcomas
SE Mahoney, Z Yao, CC Keyes, SJ Tapscott, SJ Diede
Epigenetics 7 (4), 400-408, 2012
732012
A duplication at chromosome 11q12. 2–11q12. 3 is associated with spinocerebellar ataxia type 20
MA Knight, D Hernandez, SJ Diede, HG Dauwerse, I Rafferty, ...
Human molecular genetics 17 (24), 3847-3853, 2008
702008
Spontaneous regression of metastatic cancer: learning from neuroblastoma
SJ Diede
Nature Reviews Cancer 14 (2), 71-72, 2014
642014
Pembrolizumab (pembro) in combination with dabrafenib (D) and trametinib (T) for BRAF-mutant advanced melanoma: Phase 1 KEYNOTE-022 study.
A Ribas, FS Hodi, DP Lawrence, V Atkinson, A Starodub, MS Carlino, ...
Journal of Clinical Oncology 34 (15_suppl), 3014-3014, 2016
582016
系统目前无法执行此操作,请稍后再试。
文章 1–20